| PUBLICATIONS (Ranked by Impact Factor of the Journal) | Feedback from Rhodopsin Controls Rhodopsin Exclusion in Drosophila Photoreceptors Here researchers show that the green-light sensing receptor rhodopsin 6 acts to exclude an alternative blue-sensitive rhodopsin 5 from a subset of Drosophila R8 photoreceptor neurons. [Nature] Abstract Ivy/Neurogliaform Interneurons Coordinate Activity in the Neurogenic Niche Investigators found interneurons of the neurogliaform cell family to be a primary source of GABA for newborn neurons in mouse dentate gyrus. [Nat Neurosci] Abstract Bidirectional Plasticity of Calcium-Permeable AMPA Receptors in Oligodendrocyte Lineage Cells Researchers identified factors controlling the dynamic regulation of AMPA receptor subtypes in oligodendrocyte precursor cells from rat optic nerve and mouse cerebellar cortex. [Nat Neurosci] Abstract Sleep and Waking Modulate Spine Turnover in the Adolescent Mouse Cortex Using two-photon microscopy in adolescent mice, scientists found that waking results in a net increase in cortical spines, whereas sleep is associated with net spine loss. [Nat Neurosci] Abstract CA1 Neurons in the Human Hippocampus Are Critical for Autobiographical Memory, Mental Time Travel, and Autonoetic Consciousness The results highlight the distinct and critical role of human hippocampal CA1 neurons in autobiographical memory retrieval and for re-experiencing detailed episodic memories. [Proc Natl Acad Sci USA] Abstract | Press Release Lipocalin-2 Controls Neuronal Excitability and Anxiety by Regulating Dendritic Spine Formation and Maturation Here researchers found that the lipocalin-2 gene, encoding a secreted protein of unknown neuronal function, was up-regulated in mouse hippocampus following psychological stress. [Proc Natl Acad Sci USA] Abstract Oxidative Stress Induces Overgrowth of the Drosophila Neuromuscular Junction The data suggest that reactive oxygen species, via activation of the JNK signaling pathway, are a major regulator of synapse overgrowth. [Proc Natl Acad Sci USA] Abstract | Press Release Terminally Differentiated Astrocytes Lack DNA Damage Response Signaling and Are Radioresistant but Retain DNA Repair Proficiency Here, researchers comparatively studied DNA-damage response signaling and radiosensitivity in neural stem cells and their terminally differentiated-descendants, astrocytes. [Cell Death Differ] Abstract Insulin Biosynthesis in Neuronal Progenitors Derived from Adult Hippocampus and the Olfactory Bulb Investigators demonstrated that insulin is produced not only in the mammalian pancreas but also in adult neuronal cells derived from the hippocampus and olfactory bulb. [EMBO Mol Med] Abstract | Press Release The Melatonin MT1 Receptor Axis Modulates Mutant Huntingtin-Mediated Toxicity Researchers report that melatonin delays disease onset and mortality in a transgenic mouse model of Huntington’s disease. [J Neurosci] Abstract | Press Release |
| INDUSTRY NEWS | MJFF Awards AFFiRiS $1.5 Million for the Clinical Development of the First Parkinson’s Disease Vaccine The Michael J. Fox Foundation (MJFF) announced that it has awarded $1.5 million to AFFiRiS AG for a clinical study of AFFITOPE® PD01, a first-of-its-kind Parkinson’s disease vaccine. [The Michael J. Fox Foundation for Parkinson’s Research] Press Release MagForce AG Announces Treatment of Recurrent Glioblastoma Patient with NanoTherm® Therapy MagForce AG announced the treatment of a recurrent glioblastoma patient with the company’s NanoTherm® therapy. [MagForce AG] Press Release Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform Neuralstem, Inc. announced that it has received a notice of allowance from the U.S. Patent and Trademark Office for patent application 12/418,170 pertaining to a “Spinal Platform and Method for Delivering a Therapeutic Agent to a Spinal Cord Target.” [Neuralstem, Inc.] Press Release BCM Scientists Receive Early Career Awards for Brain Cancer Research Baylor College of Medicine (BCM) researchers have received two of five national awards from The Sontag Foundation to early career scientists for unique and novel brain cancer research proposals. [Baylor College of Medicine] Press Release Ono to Enter into License Agreements with Merck KGaA Ono Pharmaceutical Co., Ltd. announced that the company signed two separate agreements with Merck KGaA on October 3, 2011 to out-license ONO-4641, a novel compound originally discovered and developed by Ono for the treatment of multiple sclerosis and to license for co-development and co-marketing Stimuvax® (candidate for product name) in Japan, a novel cancer immunotherapy, globally developed by Merck Serono. [Ono Pharmaceutical Co., Ltd.] Press Release |
|
|
|